dehydroepiandrosterone has been researched along with Fatty Liver in 11 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
Fatty Liver: Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The fatty liver induced by orotic acid and a high sucrose diet in male rats was prevented by the administration of DHEA and/or phenobarbital (PB)." | 7.70 | Prevention of orotic-acid-induced fatty liver in male rats by dehydroepiandrosterone and/or phenobarbital. ( Goto, H; Makita, T; Yamashita, S, 1998) |
| "Preventive effects of dehydroepiandrosteone acetate (DHEA-A) and clofibrate (positive control substance) on the fatty liver induced by orotic acid (OA) were examined on the male Sprague-Dawley rats fed a high sucrose based diet containing 1% OA and this diet further mixed with 0." | 7.70 | Preventive effects of dehydroepiandrosterone acetate on the fatty liver induced by orotic acid in male rats. ( Goto, H; Makita, T; Yamashita, S, 1998) |
| "This study concentrated on the initial events triggering the development of nonalcoholic fatty liver disease induced by a high-fat plus fructose (HF-F) diet and on the possibility of delaying nonalcoholic fatty liver disease progression by adding dehydroepiandrosterone (DHEA) to the diet." | 3.75 | SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats. ( Aragno, M; Boccuzzi, G; Catalano, MG; Collino, M; Danni, O; Fantozzi, R; Tomasinelli, CE; Vercellinatto, I, 2009) |
| " The fatty liver induced by orotic acid and a high sucrose diet in male rats was prevented by the administration of DHEA and/or phenobarbital (PB)." | 3.70 | Prevention of orotic-acid-induced fatty liver in male rats by dehydroepiandrosterone and/or phenobarbital. ( Goto, H; Makita, T; Yamashita, S, 1998) |
| "Preventive effects of dehydroepiandrosteone acetate (DHEA-A) and clofibrate (positive control substance) on the fatty liver induced by orotic acid (OA) were examined on the male Sprague-Dawley rats fed a high sucrose based diet containing 1% OA and this diet further mixed with 0." | 3.70 | Preventive effects of dehydroepiandrosterone acetate on the fatty liver induced by orotic acid in male rats. ( Goto, H; Makita, T; Yamashita, S, 1998) |
| "Dehydroepiandrosterone (DHEA) is a popular dietary supplement and it possesses anti-oxidative and anti-inflammatory functions; however, the effect and underlying mechanism about DHEA in protecting against the occurrence and development of FLHS remain elucidated." | 1.72 | Dehydroepiandrosterone activates the GPER-mediated AMPK signaling pathway to alleviate the oxidative stress and inflammatory response in laying hens fed with high-energy and low-protein diets. ( Jiang, Z; Ma, H; Wang, H; Yang, Y; Yao, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Yao, Y | 2 |
| Wang, H | 1 |
| Yang, Y | 1 |
| Jiang, Z | 1 |
| Ma, H | 2 |
| Li, L | 1 |
| Zhao, J | 1 |
| Cao, J | 1 |
| Manco, M | 1 |
| Bottazzo, G | 1 |
| Aragno, M | 1 |
| Tomasinelli, CE | 1 |
| Vercellinatto, I | 1 |
| Catalano, MG | 1 |
| Collino, M | 1 |
| Fantozzi, R | 1 |
| Danni, O | 1 |
| Boccuzzi, G | 1 |
| Magyar, Z | 1 |
| Bekesi, G | 1 |
| Racz, K | 1 |
| Feher, J | 1 |
| Schaff, Z | 1 |
| Lengyel, G | 1 |
| Blazovics, A | 1 |
| Illyes, G | 1 |
| Szombath, D | 1 |
| Hrabak, A | 1 |
| Szekacs, B | 1 |
| Gergics, P | 1 |
| Marczell, I | 1 |
| Dinya, E | 1 |
| Rigo, J | 1 |
| Tulassay, Z | 1 |
| Koehler, E | 1 |
| Swain, J | 1 |
| Sanderson, S | 2 |
| Krishnan, A | 2 |
| Watt, K | 1 |
| Charlton, M | 2 |
| THEA, JP | 1 |
| Angulo, P | 1 |
| Chalasani, N | 1 |
| Merriman, R | 1 |
| Viker, K | 1 |
| Charatcharoenwitthaya, P | 1 |
| Gawrieh, S | 1 |
| Lindor, K | 1 |
| Chiodera, P | 1 |
| Pignatti, D | 1 |
| Maestri, E | 1 |
| Zanardi, G | 1 |
| Degliantoni, G | 1 |
| Orlando, S | 1 |
| Volpi, R | 1 |
| Delsignore, R | 1 |
| Goto, H | 2 |
| Yamashita, S | 2 |
| Makita, T | 2 |
11 other studies available for dehydroepiandrosterone and Fatty Liver
| Article | Year |
|---|---|
Dehydroepiandrosterone activates the GPER-mediated AMPK signaling pathway to alleviate the oxidative stress and inflammatory response in laying hens fed with high-energy and low-protein diets.
Topics: Abnormalities, Multiple; AMP-Activated Protein Kinases; Animal Feed; Animals; Antioxidants; Chickens | 2022 |
Dehydroepiandrosterone protects against hepatic glycolipid metabolic disorder and insulin resistance induced by high fat via activation of AMPK-PGC-1α-NRF-1 and IRS1-AKT-GLUT2 signaling pathways.
Topics: AMP-Activated Protein Kinases; Animals; Dehydroepiandrosterone; Fatty Liver; Glucose Transporter Typ | 2020 |
Does the hormone of eternal youth protect against nonalcoholic steatohepatitis?
Topics: Adiponectin; Dehydroepiandrosterone; Disease Progression; Fatty Acids, Nonesterified; Fatty Liver; H | 2008 |
SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats.
Topics: Animals; Cell Death; Dehydroepiandrosterone; Dietary Fats; Fatty Liver; Fructose; Hyperlipidemias; I | 2009 |
Increased total scavenger capacity and decreased liver fat content in rats fed dehydroepiandrosterone and its sulphate on a high-fat diet.
Topics: Administration, Oral; Animals; Antioxidants; Catalase; Dehydroepiandrosterone; Dehydroepiandrosteron | 2011 |
Growth hormone, dehydroepiandrosterone and adiponectin levels in non-alcoholic steatohepatitis: an endocrine signature for advanced fibrosis in obese patients.
Topics: Adiponectin; Biomarkers; Dehydroepiandrosterone; Fatty Liver; Female; Growth Hormone; Humans; Liver | 2012 |
[1-methyl-delta-1-androstenolone enanthate in hepatic steatosis].
Topics: Dehydroepiandrosterone; Fatty Liver; Heptanoates; Humans | 1963 |
Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.
Topics: Adiponectin; Adult; Biomarkers; Biopsy; Blood Glucose; C-Reactive Protein; Cohort Studies; Dehydroep | 2008 |
[Blood levels of prolactin, dehydroepiandrosterone sulfate, cortisol, testosterone and 17-beta-estradiol in chronic alcoholism].
Topics: Adult; Alcoholism; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Fatty Liver; H | 1981 |
Prevention of orotic-acid-induced fatty liver in male rats by dehydroepiandrosterone and/or phenobarbital.
Topics: Analysis of Variance; Animals; Cells, Cultured; Dehydroepiandrosterone; Dietary Sucrose; Energy Inta | 1998 |
Preventive effects of dehydroepiandrosterone acetate on the fatty liver induced by orotic acid in male rats.
Topics: Animals; Clofibrate; Dehydroepiandrosterone; Diet; Fatty Liver; Hypolipidemic Agents; Liver; Male; M | 1998 |